Table:
begin	end	state
1	20	cytoplasmic
21	40	transmembrane
41	58	non-cytoplasmic
59	78	transmembrane
79	88	cytoplasmic
89	111	transmembrane
112	161	non-cytoplasmic
162	180	transmembrane
181	195	cytoplasmic
196	218	transmembrane
219	235	non-cytoplasmic
236	259	transmembrane
260	295	cytoplasmic
296	312	transmembrane
313	317	non-cytoplasmic
318	336	transmembrane
337	341	cytoplasmic
342	387	transmembrane
388	438	cytoplasmic

Input:
>WP_144428314.1 NCBI__GCF_001305595.1:WP_144428314.1
MSADAIAARPGTVKKPFYTNLTFQVLTAISIGILLGHFYPAIAVQMKPLGDLFIKMVKMV
IGPIVFLTVVTGISSIGNLKKVGKVGGKALLYFEVVTTFALGIGLLIVNLVRPGAGMNIQ
PGQLKADAVQKYATSAHEHGFIDFVVGIVPDNVVGAFVQGDMLQILFFAVVFGVALSAMG
QKGKLVEDIFDKIGHALFGVIGILMRVAPVGAFGAMSFTIGKYGISSLTALGQLMASVYI
TMAIFIFVVLGGIAKAYGFSIWSFIRYIRQELLIVLGTSSSESVLPRMMEKMQKFGCSKH
VVGLVIPTGYSFNLDGTSIYLSMAAIFIAQAFNVDLTIWQQLYILVILMLTSKGAAAVTG
GGFVTLAATLSATGVLPIEGLALLLGVDRFMSEARALTNLIGNGVATVVVAKMEGEFDET
RAVAEYQQHFKEPALARI

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server